Holen Sie sich die Stockscreener-App
319.22
0.29%
-0.94
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$320.16
Offen:
$318.69
24-Stunden-Volumen:
1.65M
Relative Volume:
0.94
Marktkapitalisierung:
$171.74B
Einnahmen:
$32.53B
Nettoeinkommen (Verlust:
$4.23B
KGV:
22.69
EPS:
14.07
Netto-Cashflow:
$6.28B
1W Leistung:
+0.71%
1M Leistung:
-0.34%
6M Leistung:
+15.09%
1J Leistung:
+22.38%
1-Tages-Spanne:
$316.91
$321.69
1-Wochen-Bereich:
$310.63
$323.40
52-Wochen-Spanne:
$260.52
$346.85
Amgen Inc Stock (AMGN) Company Profile
Firmenname
Amgen Inc
Sektor
Telefon
(805)447-1000
Adresse
ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA
Amgen Inc Stock (AMGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-03-28 | Fortgesetzt | Raymond James | Mkt Perform |
| 2024-02-07 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2023-12-21 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2023-12-19 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-12-12 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-11-02 | Hochstufung | Truist | Hold → Buy |
| 2023-10-20 | Fortgesetzt | JP Morgan | Neutral |
| 2023-10-17 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2023-10-11 | Fortgesetzt | BofA Securities | Neutral |
| 2023-09-06 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-24 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-13 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-02-13 | Bestätigt | Truist | Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Underperform |
| 2022-10-31 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-10-11 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-05-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2022-02-09 | Bestätigt | Barclays | Equal Weight |
| 2022-02-09 | Bestätigt | Jefferies | Buy |
| 2022-02-09 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-02-09 | Bestätigt | Oppenheimer | Outperform |
| 2022-02-09 | Bestätigt | Wells Fargo | Equal Weight |
| 2022-01-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2021-12-06 | Eingeleitet | Goldman | Buy |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-09-23 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-29 | Eingeleitet | Daiwa Securities | Buy |
| 2020-10-28 | Eingeleitet | UBS | Neutral |
| 2020-10-26 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-10-12 | Hochstufung | Truist | Hold → Buy |
| 2020-10-09 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2020-10-09 | Herabstufung | Truist | Buy → Hold |
| 2020-10-08 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2020-04-15 | Fortgesetzt | Guggenheim | Neutral |
| 2020-03-31 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-03-30 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2020-03-05 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-01-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2020-01-21 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2019-12-24 | Eingeleitet | Raymond James | Mkt Perform |
| 2019-12-17 | Fortgesetzt | Morgan Stanley | Overweight |
| 2019-11-12 | Eingeleitet | SunTrust | Buy |
| 2019-11-05 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-19 | Herabstufung | Mizuho | Buy → Neutral |
| 2019-05-23 | Hochstufung | Citigroup | Neutral → Buy |
Alle ansehen
Amgen Inc Aktie (AMGN) Neueste Nachrichten
Amgen : Championing Quality Every Day - Marketscreener.com
Championing Quality Every Day - Amgen
Stephens Inc. AR Has $16.99 Million Stock Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
What is William Blair's Estimate for Amgen FY2024 Earnings? - MarketBeat
The Art of Valuation: Discovering Amgen Inc's Intrinsic Value - Yahoo Finance
Amgen Third Quarter 2024 Earnings: EPS Beats Expectations - Yahoo Finance
Decoding Amgen Inc (AMGN): A Strategic SWOT Insight - Yahoo Finance UK
Collaboration and Community Engagement: Two Powerful Ways to Improve Health - Amgen
Earnings call: Amgen reports robust Q3 growth with $8.5 billion in revenue - Investing.com
Amgen Whets Investors’ Appetites for MariTide Obesity Data by End of Year - BioSpace
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Oak Harvest Investment Services - MarketBeat
Amgen Q3 Earnings Beat, Sales In Line, Obesity Candidate in Focus - Yahoo Finance
Stellar 2024 third-quarter for Amgen - The Pharma Letter
Amgen: EPS up 13% in Q3 - Marketscreener.com
Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline ... - Yahoo Finance
Amgen Inc (AMGN) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Pipeline Advancements - GuruFocus.com
Amgen Shines With Earnings Boost From Repatha And Prolia - Finimize
Amgen’s Q3 2024: Strong Sales and Strategic Growth - TipRanks
Amgen posts higher profit, obesity data on track for late this year - Reuters
Compared to Estimates, Amgen (AMGN) Q3 Earnings: A Look at Key Metrics - Yahoo Finance
Amgen Is 'Laser-Focused' On Obesity With Pfizer Following - Investor's Business Daily
Amgen (AMGN) Beats Q3 Earnings Estimates - Yahoo Finance
Amgen Inc (AMGN) Q3 2024 Earnings: Revenue Surges to $8.5 Billio - GuruFocus.com
Amgen Posts Higher 3Q Sales on Strong Demand - Marketscreener.com
Amgen beats Q3 earnings estimates, raises full-year guidance By Investing.com - Investing.com Canada
Amgen posts higher 3rd-quarter profit, sales rise 24% - Marketscreener.com
Amgen reports revenue of $8.5B in Q3, up 23% - baha news
Amgen’s Profit Beats Expectations on Lower Than Estimated Costs - Bloomberg
AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS - PR Newswire
PREVIEW: Amgen edges lower with results on tap - XM
Highline Wealth Partners LLC Takes $1.30 Million Position in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Imdelltra: the 200 Best Inventions of 2024 - TIME
Amgen Inc. stock outperforms competitors despite losses on the day - MarketWatch
Amgen Q3 2024 Earnings Preview: All eyes on obesity candidate data (NASDAQ:AMGN) - Seeking Alpha
Learn to Evaluate (AMGN) using the Charts - Stock Traders Daily
Amgen Inc. (NASDAQ:AMGN) is a favorite amongst institutional investors who own 79% - Yahoo Finance
Strategic Wealth Investment Group LLC Raises Stock Holdings in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. stock rises Monday, still underperforms market - MarketWatch
Amgen's SWOT analysis: stock outlook hinges on obesity drug success - Investing.com
Amgen's SWOT analysis: stock outlook hinges on obesity drug success By Investing.com - Investing.com UK
First American Bank Has $4.18 Million Stake in Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Zacks Research Forecasts Amgen's Q1 Earnings (NASDAQ:AMGN) - MarketBeat
Highland Capital Management LLC Sells 2,478 Shares of Amgen Inc. (NASDAQ:AMGN) - MarketBeat
Amgen Inc. (NASDAQ:AMGN) Shares Sold by Louisiana State Employees Retirement System - MarketBeat
2 Reliable Dividend Stocks You Can Buy and Hold Forever - The Motley Fool
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - MSN
Amgen Inc. Declares Quarterly Dividend of $2.25 (NASDAQ:AMGN) - MarketBeat
Amgen sets $2.25 per share Q4 dividend - Investing.com
AMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND - PR Newswire
Sen. Elizabeth Warren tells FTC she remains concerned about Amgen's Horizon deal - MSN
Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List (AMGN) - Seeking Alpha
Finanzdaten der Amgen Inc-Aktie (AMGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Amgen Inc-Aktie (AMGN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Grygiel Nancy A. | SVP & CCO |
Dec 04 '23 |
Sale |
273.03 |
2,096 |
572,276 |
10,874 |
| Graham Jonathan P | EVP, Gen. Counsel & Secy. |
Nov 08 '23 |
Sale |
272.81 |
10,000 |
2,728,136 |
28,078 |
0.74%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):